Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-10

Clinical Trial Update: Long-Term Safety and Efficacy of Moxifloxacin in Bronchiectasis Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the long-term safety and efficacy of moxifloxacin in non-Cystic Fibrosis bronchiectasis is described, and the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Assiut University | Conditions: Bronchiectasis, Non-Cystic Fibrosis | Phase 3 | Status: NOT_YET_RECRUITING